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Introduction
Irritable bowel syndrome (IBS) is the most prevalent functional gastrointestinal disorder with a complex and unclear etiology. It has numerous pathogenic factors, including chronic stress 1 and disorders of intestinal microbiota. 2 Various preparations are used in the treatment of this condition, but usually without long-lasting outcomes. The diagnosis of IBS is based on the exclusion of organic changes in the gastrointestinal tract; therefore, biochemical markers are still being sought. Changes in the homeostasis of neurotransmitters such as serotonin and dopamine, which are involved in the regulation of all gastrointestinal activities and have a substantial impact on the person's emotional state, are particularly interesting. 3, 4 The aim of this study was to evaluate the secretion and metabolism of serotonin and dopamine in relation to clinical subtypes of IBS.
Patients and methods
The study included 98 participants divided into 3 groups: group 1, clinically healthy individuals (n = 32); group 2, patients with diarrhea -predominant IBS (IBS -D; n = 40); and group 3, patients with constipation--predominant IBS (IBS -C; n = 36) with symptom onset at least 6 months prior to the diagnosis. The mean (SD) age of participants in group 1 was 31.9 (8.82) years; in group 2, 32.8 (9.77) years; and in group 3, 33.6 (9.47) years. The diagnosis of IBS was based on Rome IV criteria. All patients enrolled in the study underwent gastroscopy, colonoscopy, histopathologic examination of gastric, duodenal, and colonic mucosa, comprehensive laboratory tests, lactulose hydrogen breath test, and bacteriological stool examination.
The exclusion criteria were as follows: microscopic changes of colonic mucosa; metabolic,
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Evaluation of serotonin and dopamine secretion and metabolism in patients with irritable bowel syndrome constipation. In IBS -D, 5 -HT3 receptor antagonists have been used; however, due to serious side effects, their administration has been limited. 10 For this reason, new drugs, especially tryptophan hydroxylase inhibitors, are currently under investigation in clinical trials.
Our results indicate that serotonin homeostasis is altered in IBS patients. This confirms that in order to understand functional and inflammatory diseases of the gastrointestinal tract, it is crucial to elucidate the mechanisms of serotonin synthesis and metabolism. Increased serotonin synthesis in the gastrointestinal tract may result from the proliferation of enterochromaffin cells and enhanced activity of synthesizing enzymes. The contribution of nutritional factors is important, including consumed food products containing various amounts of exogenous tryptophan and phenylalanine. This process is also enhanced by inflammatory cytokines 5 and bacterial metabolites. 11 Moreover, some microorganisms can synthesize serotonin and other biologically active compounds, 12 thus maintaining microbial balance in the gastrointestinal tract should also be the target of IBS therapy.
In our patients with IBS -D, the blood levels of serotonin and the urinary levels of its metabolite were significantly higher compared with those in healthy controls and patients with IBS -C. However, patients with IBS -C had higher plasma dopamine and urinary HVA levels. Of note, there were significant differences between IBS groups in the 5 -HIAA/HVA ratio, which shows that this paramater may be useful in the differential diagnosis of both types of IBS and other gastrointestinal disorders.
In conclusion, our preliminary results showed that serotonin and dopamine secretion is altered to varying degrees in patients with IBS, which may established at a P level of less than 0.05. Statistica 9.1 (StatSoft Polska Sp. z o.o., Kraków, Poland) and Microsoft Excel were used for calculations.
Results Controls, patients with IBS-D, and patients with IBS-C did not differ in terms of age and sex (TABLE 1). Differences in laboratory parameters such as serotonin, dopamine, 5-HIAA, and HVA levels, as well as 5-HIAA/HVA ratio between the study groups are presented in detail in TABLE 1.
Discussion
The digestive system is a rich source of serotonin (about 90%) in the human body. Serotonin is synthesized mainly in enterochromaffin cells located in all parts of the gastrointestinal tract. These cells are abundant in the large intestine, both in the epithelium and in the glandular part. Tryptophan, an exogenous amino acid, is the substrate of serotonin synthesis. The synthesis involves the participation of tryptophan hydroxylase and 5 -tryptophan decarboxylase, as well as 5 -HIAA as its final metabolite. 5 Serotonin stimulates intestinal motility and secretory function by paracrine and endocrine pathways through 5 -HT2, 5 -HT3, and 5 -HT4 receptors. 6 Its excess, for example, in a carcinoid tumor, causes persistent diarrhea. In physiological states, dopamine (which is secreted by, among others, nonneural cells in the gastrointestinal tract) counteracts excessive stimulation of these activities. 7 Exogenous phenylalanine and tyrosine are substrates of its synthesis, and tyrosine hydroxylase and aromatic amino acid decarboxylase are the relevant catalyzing enzymes. Dopamine inhibits motor activity and shows antisecretory activity mainly via D2 receptor. Based on this knowledge, 5 -HT4 tryptamine receptor agonists or 5 -HT3 receptor antagonists, 8 as well as dopamine D2 receptor antagonists, 9 are used in the therapy of Data are presented as mean (SD) unless otherwise indicated. A P value of less than 0.05 was considered significant.
a IBS-C vs IBS-D; b IBS-D vs controls; c IBS-C vs controls Abbreviations: 5 -HIAA, 5 -hydroxyindoleacetic acid; HVA, homovanillic acid; IBS -C, irritable bowel syndrome with predominant constipation; IBS -D, irritable bowel syndrome with predominant diarrhea determine the type of clinical symptoms. Evaluation of the 5 -HIAA/HVA ratio may be a useful noninvasive test in the differential diagnosis of clinical types of IBS. However, further studies are needed to confirm the role of the serotoninergic and dopaminergic system in the pathogenesis of IBS and the utility of the 5 -HIAA/HVA ratio in its diagnosis.
